CURRENT AFFAIRS

Detailed explanation-1: -The Minister launched on the occasion: Bedaquiline, the new anti-TB drug for Drug Resistant TB under the conditional access program. The drug is first anti-TB drug discovered in nearly 40 years. Third line ART programme for People Living with HIV; the life-saving third line ART costs nearly Rs.

Detailed explanation-2: -The National Tuberculosis Elimination Programme (NTEP), previously known as Revised National Tuberculosis Control Programme (RNTCP), aims to strategically reduce TB burden in India by 2025, five years ahead of the Sustainable Development Goals.

Detailed explanation-3: -Kargil, Nov 21, 2022: Chairman/CEC, LAHDC, Kargil, Feroz Ahmed Khan today launched Nikshay Mitra, a Community Support initiative for TB Patients under Pradhan Mantri TB Mukt Bharat Abhiyaan at Conference Hall Kargil.

Detailed explanation-4: -The NIKSHA 2.0 portal provides additional patient support to TB patients to take advantage of Corporate Social Responsibility (CSR) opportunities to improve treatment outcomes, enhance community participation and fulfill India’s commitment to TB eradication by 2025.